Sumitomo Mitsui DS Asset Management Company Ltd Raises Position in Leidos Holdings, Inc. (NYSE:LDOS)

Sumitomo Mitsui DS Asset Management Company Ltd boosted its position in Leidos Holdings, Inc. (NYSE:LDOS) by 1.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 14,378 shares of the aerospace company’s stock after purchasing an additional 239 shares during the period. Sumitomo Mitsui DS Asset Management Company Ltd’s holdings in Leidos were worth $2,344,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. 1832 Asset Management L.P. purchased a new position in shares of Leidos in the second quarter valued at $34,000. Blue Trust Inc. increased its holdings in Leidos by 251.3% during the 2nd quarter. Blue Trust Inc. now owns 281 shares of the aerospace company’s stock valued at $41,000 after acquiring an additional 201 shares in the last quarter. Massmutual Trust Co. FSB ADV lifted its holdings in shares of Leidos by 122.5% in the second quarter. Massmutual Trust Co. FSB ADV now owns 307 shares of the aerospace company’s stock valued at $45,000 after purchasing an additional 169 shares in the last quarter. Kathleen S. Wright Associates Inc. acquired a new stake in shares of Leidos in the third quarter valued at approximately $46,000. Finally, Family Firm Inc. acquired a new position in shares of Leidos during the 2nd quarter worth approximately $60,000. Institutional investors and hedge funds own 76.12% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on the company. Truist Financial boosted their price target on Leidos from $165.00 to $175.00 and gave the stock a “buy” rating in a report on Thursday, September 5th. Bank of America boosted their price objective on shares of Leidos from $160.00 to $165.00 and gave the company a “buy” rating in a research report on Wednesday, August 7th. Royal Bank of Canada boosted their price target on Leidos from $140.00 to $145.00 and gave the company a “sector perform” rating in a report on Wednesday, July 31st. Stifel Nicolaus lifted their price objective on Leidos from $160.00 to $165.00 and gave the company a “buy” rating in a research report on Monday, June 24th. Finally, Barclays raised their price target on Leidos from $160.00 to $165.00 and gave the stock an “overweight” rating in a research note on Monday, August 5th. Two analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, Leidos has an average rating of “Moderate Buy” and an average target price of $166.92.

Insider Transactions at Leidos

In other Leidos news, CEO Thomas Arthur Bell bought 1,712 shares of the firm’s stock in a transaction dated Thursday, August 1st. The stock was acquired at an average price of $145.04 per share, with a total value of $248,308.48. Following the completion of the transaction, the chief executive officer now directly owns 22,398 shares in the company, valued at approximately $3,248,605.92. This represents a 0.00 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, CEO Thomas Arthur Bell acquired 1,712 shares of the business’s stock in a transaction that occurred on Thursday, August 1st. The stock was acquired at an average cost of $145.04 per share, for a total transaction of $248,308.48. Following the completion of the acquisition, the chief executive officer now owns 22,398 shares in the company, valued at approximately $3,248,605.92. The trade was a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Robert C. Kovarik, Jr. sold 1,059 shares of the company’s stock in a transaction dated Thursday, August 1st. The stock was sold at an average price of $145.23, for a total value of $153,798.57. Following the completion of the transaction, the director now directly owns 7,455 shares in the company, valued at approximately $1,082,689.65. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.96% of the stock is owned by insiders.

Leidos Price Performance

Shares of NYSE:LDOS opened at $169.66 on Tuesday. The company has a quick ratio of 1.11, a current ratio of 1.21 and a debt-to-equity ratio of 0.91. The firm has a 50-day simple moving average of $158.38 and a 200 day simple moving average of $148.44. Leidos Holdings, Inc. has a fifty-two week low of $90.30 and a fifty-two week high of $170.15. The company has a market cap of $22.85 billion, a PE ratio of 53.19, a P/E/G ratio of 1.51 and a beta of 0.70.

Leidos (NYSE:LDOS) last issued its quarterly earnings data on Tuesday, July 30th. The aerospace company reported $2.63 earnings per share for the quarter, beating the consensus estimate of $2.27 by $0.36. The firm had revenue of $4.13 billion for the quarter, compared to the consensus estimate of $4.06 billion. Leidos had a net margin of 2.72% and a return on equity of 28.40%. Leidos’s quarterly revenue was up 7.7% compared to the same quarter last year. During the same period last year, the firm posted $1.80 EPS. On average, sell-side analysts anticipate that Leidos Holdings, Inc. will post 8.96 EPS for the current year.

Leidos Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, September 27th. Shareholders of record on Friday, September 13th were issued a $0.38 dividend. The ex-dividend date of this dividend was Friday, September 13th. This represents a $1.52 annualized dividend and a dividend yield of 0.90%. Leidos’s dividend payout ratio is currently 47.65%.

Leidos Company Profile

Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.